Holen Sie sich die Stockscreener-App
362.94
0.82%
-4.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$367.36
Offen:
$366.6
24-Stunden-Volumen:
100.66K
Relative Volume:
0.33
Marktkapitalisierung:
$16.40B
Einnahmen:
$2.76B
Nettoeinkommen (Verlust:
$1.11B
KGV:
15.94
EPS:
22.77
Netto-Cashflow:
$898.10M
1W Leistung:
-1.69%
1M Leistung:
-0.99%
6M Leistung:
+3.62%
1J Leistung:
+66.23%
1-Tages-Spanne:
$362.52
$369.00
1-Wochen-Bereich:
$362.50
$383.50
52-Wochen-Spanne:
$214.75
$417.81
United Therapeutics Corp Stock (UTHR) Company Profile
Firmenname
United Therapeutics Corp
Sektor
Branche
Telefon
(301) 608-9292
Adresse
1000 SPRING ST, SILVER SPRING, MD
Vergleichen Sie UTHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
362.75 | 16.40B | 2.76B | 1.11B | 898.10M | 22.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
480.59 | 123.34B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
696.46 | 76.09B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
647.50 | 39.34B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.88 | 32.49B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
117.10 | 28.26B | 3.30B | -501.07M | 1.03B | -2.1146 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Hochstufung | Goldman | Sell → Neutral |
| 2024-02-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-06 | Eingeleitet | UBS | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Sell |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-20 | Bestätigt | BofA Securities | Underperform |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-02-11 | Eingeleitet | BTIG Research | Neutral |
| 2021-07-14 | Hochstufung | Argus | Hold → Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-02-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-06-25 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-03-10 | Hochstufung | Jefferies | Hold → Buy |
| 2020-02-27 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-01-31 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Eingeleitet | BofA/Merrill | Underperform |
| 2019-08-01 | Hochstufung | Jefferies | Underperform → Hold |
| 2019-08-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Hochstufung | Standpoint Research | Hold → Buy |
| 2018-08-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Barclays | Underweight |
| 2018-01-18 | Fortgesetzt | Credit Suisse | Underperform |
| 2017-12-27 | Bestätigt | Wedbush | Outperform |
| 2017-04-27 | Bestätigt | Wedbush | Outperform |
| 2017-03-30 | Eingeleitet | UBS | Sell |
| 2017-03-16 | Eingeleitet | Credit Suisse | Underperform |
Alle ansehen
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
United Therapeutics Co. (NASDAQ:UTHR) COO Sells $3,710,500.00 in Stock - MarketBeat
New York State Teachers Retirement System Lowers Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (UTHR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Allspring Global Investments Holdings LLC Cuts Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
AustralianSuper Pty Ltd Buys 161,751 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Quent Capital LLC Sells 3,232 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (UTHR) Projected to Post Earnings on Wednesday - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Empirical Finance LLC - MarketBeat
United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN
Empowered Funds LLC Lowers Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength? - Yahoo Finance
United Therapeutics' president sells shares worth $3.48 million - MSN
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) COO Sells 10,000 Shares of Stock - MarketBeat
United Therapeutics Corporation (UTHR): A Cheap Biotech Stock to Invest In Now - Insider Monkey
United Therapeutics' president sells shares worth $3.48 million By Investing.com - Investing.com Australia
Livforsakringsbolaget Skandia Omsesidigt Has $9.90 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics’ president sells shares worth $3.48 million By Investing.com - Investing.com Nigeria
United Therapeutics Corp. to Host Earnings Call - ACCESS Newswire
Polaris Capital Management LLC Decreases Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (NASDAQ:UTHR) Sees Strong Trading VolumeWhat's Next? - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Holdings Lowered by Tobam - MarketBeat
United Therapeutics president sells $3.5m in stock - MSN
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial - Dallas Business Journal
State Street Corp Reduces Stake in United Therapeutics Corp - GuruFocus.com
UTHRUnited Therapeutics Corp Latest Stock News & Market Updates - StockTitan
United Therapeutics president sells $3.5m in stock By Investing.com - Investing.com Australia
China Universal Asset Management Co. Ltd. Purchases 909 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
FDA approves pig organ transplant trials for patients with kidney failure - The Washington Post
United Therapeutics Corporation's (NASDAQ:UTHR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
US FDA greenlights clinical trails for pig kidney transplants in humans - MSN
Breakthrough IPF Treatment Study Hits Key Milestone: 598 Patients Enrolled in Game-Changing Tyvaso Trial - StockTitan
US approves trials for pig kidney transplants in humans - NewsBytes
Short Interest in United Therapeutics Co. (NASDAQ:UTHR) Declines By 14.3% - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Stock Holdings Raised by Janney Montgomery Scott LLC - MarketBeat
United Therapeutics (NASDAQ:UTHR) Stock Price Down 4.9%Here's What Happened - MarketBeat
Finanzdaten der United Therapeutics Corp-Aktie (UTHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
United Therapeutics Corp-Aktie (UTHR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 18 '25 |
Sale |
371.05 |
10,000 |
3,710,499 |
0 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 10 '25 |
Option Exercise |
111.00 |
10,000 |
1,110,000 |
7,500 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 10 '25 |
Sale |
348.06 |
10,000 |
3,480,642 |
0 |
| MAHON PAUL A | EVP & GENERAL COUNSEL |
Feb 06 '25 |
Option Exercise |
163.30 |
7,700 |
1,257,410 |
44,410 |
0.28%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):